Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019

被引:2
|
作者
Razonable, Raymund R. [1 ]
Ganesh, Ravindra [1 ]
Bishop, Rachel K. [2 ]
Culbertson, Tracy L. [3 ]
Borgen, Molly Destro [1 ]
Hedin, Michelle C. [1 ]
Hopkins, Laura H. [3 ]
Jackson, Tammy A. [4 ]
Larsen, Jennifer J. [1 ]
Matoush, Jennifer A. [1 ]
Moehnke, Darcie E. [1 ]
Olson, Shelly M. [5 ]
Peterson, Kellie M. [6 ]
Rosedahl, Jordan [1 ]
Philpot, Lindsey M. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin Hlth Syst Franciscan Healthcare, La Crosse, WI USA
[3] Mayo Clin Hlth Syst, Mankato, MN USA
[4] Mayo Clin Hlth Syst, Eau Claire, WI USA
[5] Mayo Clin Hlth Syst, Owatonna, MN USA
[6] Mayo Clin Hlth Syst, Albert Lea, MN USA
来源
关键词
COVID-19; monoclonal antibodies; bamlanivimab; casirivimab; infusion; FRAMEWORK;
D O I
10.1177/23743735221105673
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Anti-spike monoclonal antibodies emerged as effective early treatment of high-risk individuals with mild-to-moderate COVID-19. Although their clinical and safety outcomes have been reported, patient perspectives of these experimental therapies have not been evaluated. In this survey participated by 644/2412 (26.7% response) individuals evaluated for anti-spike monoclonal antibody therapies, the majority of 523 patients who received the antibody infusion were very satisfied with their overall patient experience, the quality of care provided, and various aspects of medical care. They voiced satisfaction with the communication with providers before and during treatment, including education provided about monoclonal antibody treatment, the potential benefits and adverse effects, detailed instructions on the process of infusion, and safety protocols employed at the infusion facilities. Nearly a quarter (23.6%) of 121 patients who declined therapy indicated they would accept treatment should it be offered again. These patient perspectives may be used to guide healthcare facilities and providers in optimizing the care provided to high-risk outpatients with COVID-19.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience Reply
    Ganesh, Ravindra
    Philpot, Lindsey M.
    Bierle, Dennis M.
    Razonable, Raymund R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (02): : 354 - 355
  • [32] Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
    Phan, Tin
    Zitzmann, Carolin
    Chew, Kara W.
    Smith, Davey M.
    Daar, Eric S.
    Wohl, David A.
    Eron, Joseph J.
    Currier, Judith S.
    Hughes, Michael D.
    Choudhary, Manish C.
    Deo, Rinki
    Li, Jonathan Z.
    Ribeiro, Ruy M.
    Ke, Ruian
    Perelson, Alan S.
    [J]. PLOS PATHOGENS, 2024, 20 (04)
  • [33] Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients
    Yetmar, Zachary A.
    Bhaimia, Eric
    Razonable, Raymund R.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2022, 27 (04) : 269 - 276
  • [34] Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
    Liao, Xuejiao
    Li, Dapeng
    Liu, Jie
    Liu, Zhi
    Ma, Zhenghua
    Dong, Jingke
    Yang, Xiangyi
    Shu, Dan
    Yuan, Jing
    Liu, Lei
    Zhang, Zheng
    [J]. VIROLOGY JOURNAL, 2022, 19 (01)
  • [35] Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
    Xuejiao Liao
    Dapeng Li
    Jie Liu
    Zhi Liu
    Zhenghua Ma
    Jingke Dong
    Xiangyi Yang
    Dan Shu
    Jing Yuan
    Lei Liu
    Zheng Zhang
    [J]. Virology Journal, 19
  • [36] Does Previous Anti-thrombotic Use Affect the Course of Coronavirus Disease-2019?
    Onur, Imran
    Onur, Seda Tural
    Gunluoglu, Gulsah
    Bingol, Gulsum
    Sokucu, Sinem Nedime
    Ozden, Ozge
    Nasifov, Muharrem
    Bolat, Erkut
    Toptas, Mehmet
    Altin, Sedat
    [J]. ISTANBUL MEDICAL JOURNAL, 2022, 23 (04): : 301 - 305
  • [37] The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019
    Lupu, Lior
    Banai, Ariel
    Szekely, Yishay
    Lichter, Yael
    Hochstadt, Aviram
    Taieb, Philippe
    Sapir, Orly
    Granot, Yoav
    Merdler, Ilan
    Ghantous, Eihab
    Borohovitz, Ariel
    Sadon, Sapir
    Levi, Erez
    Laufer-Perl, Michal
    Banai, Shmuel
    Topilsky, Yan
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 492 - 499
  • [38] Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection
    Seecheran, Rajeev
    Narayansingh, Roshni
    Giddings, Stanley
    Rampaul, Marlon
    Furlonge, Kurt
    Abdool, Kamille
    Bhagwandass, Neal
    Seecheran, Naveen Anand
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2020, 8
  • [39] Atrial fibrillation in a patient presenting with coronavirus disease-2019 (COVID-19) infection
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N73 - N73
  • [40] Coronavirus Disease-2019 Pandemic Effects on Patient Decisions Regarding Clinical Trial Participation
    Kharasch, Evan D.
    Schlabaugh, Carrie
    Metzler, Emmalee
    Schultz, Alicja
    [J]. ANESTHESIA AND ANALGESIA, 2024, 138 (04): : 906 - 908